This site is private for the moment. Enter the password to continue.

nLIV — fertility supplements

Reproductive health,
formulated with rigor.

nLIV develops clinical-grade supplements for women's and men's fertility, built on a small, deliberately narrow line — every formulation chosen for a specific role in reproductive health, not a shelf of look-alikes.

FORMULATION INDEX / 2026

6 active formulations

Each product targets one mechanism in the fertility pathway — ovarian reserve, cellular energy, systemic vitamin status, antioxidant protection, or foundational micronutrition.

2
Audiences supported
6
Products in the line

01 / WOMEN

For women

Ovarian reserve, egg quality and foundational micronutrient support.

Shop women's

02 / MEN

For men

Cellular energy and systemic support for sperm health.

Shop men's

03 / BOTH

For both

Shared formulations designed to support both partners at once.

Shop shared

The core line

Formulated for one job each.

nLIV / DHEA‑01 Women

nLIV DHEA

Micronized DHEA

Supports ovarian reserve and egg quality as part of a preconception routine, in a micronized form chosen for absorption.

Dose
25 mg / capsule
Format
Capsule
Focus
Ovarian reserve
Pack size
90 capsules
nLIV / COQ10‑02 Both

nLIV CoQ10

Ubiquinol CoQ10

Supports the cellular energy production that egg and sperm cells rely on during development, in the active ubiquinol form.

Dose
100 mg / softgel
Format
Softgel
Focus
Cellular energy
Pack size
30 softgels
nLIV / D3K2‑03 Both

nLIV D3 + K2

Vitamin D3 with K2

Corrects a common gap in reproductive health, supporting systemic vitamin D status alongside proper vitamin K2 utilization.

Dose
2000 IU + 90 mcg
Format
Softgel
Focus
Systemic support
Pack size
30 softgels
nLIV / MULTI‑04 Women

nLIV Multivitamin

Complete fertility multivitamin

A foundational multivitamin covering the core micronutrients relevant to preconception and reproductive health in one formulation.

Dose
1 tablet / serving
Format
Tablet
Focus
Foundational
Pack size
30 tablets
nLIV / RESV‑05 Women

nLIV Resveratrol

Trans-resveratrol

A plant-derived antioxidant studied for its effect on oxidative stress in the ovary, taken at a lower, conservative dose given some conflicting findings on higher intakes.

Dose
150 mg / capsule
Format
Capsule
Focus
Ovarian antioxidant support
Pack size
30 capsules
nLIV / FOLIC‑06 Women

nLIV Folic Acid

Folic acid

A standalone preconception folate, for anyone who wants the single best-established fertility nutrient on its own rather than folded into a multivitamin.

Dose
800 mcg / tablet
Format
Tablet
Focus
Neural tube protection
Pack size
30 tablets

Research & rationale

Why each ingredient made the line.

Nothing enters the nLIV line without a documented mechanism. Below is the reasoning behind each formulation, along with a short reading list for anyone who wants to go to the primary sources. Where the evidence is mixed, we say so rather than round it up.

nLIV / DHEA‑01

DHEA

DHEA is an adrenal androgen involved in early follicle development. Several retrospective studies and meta-analyses in women with diminished ovarian reserve report higher clinical pregnancy rates following DHEA pretreatment before IVF, though the effect on the number of eggs retrieved is less consistent, and the largest randomized trials show a smaller benefit than the observational data. We formulated to the micronized dose used in most of this research rather than to a rounder, more marketable number.

Further reading
  • Chern et al., "Dehydroepiandrosterone supplementation improves the outcomes of in vitro fertilization cycles in older patients with diminished ovarian reserve," Frontiers in Endocrinology, 2019.
  • Narkwichean et al., "Efficacy of dehydroepiandrosterone to improve ovarian response in women with diminished ovarian reserve: a meta-analysis," Reproductive Biology and Endocrinology.
nLIV / COQ10‑02

CoQ10

Egg and sperm cells are unusually energy-intensive, and mitochondrial output in both declines with age. Laboratory work has shown that restoring CoQ10 levels can reverse age-related mitochondrial decline in oocytes, and clinical reviews report improved ovarian response and embryo quality with CoQ10 pretreatment in women with weaker ovarian reserve. The evidence base is genuinely promising rather than settled — most authors are still calling for larger randomized trials, and we think that distinction matters more than a confident marketing claim would.

Further reading
  • Ben-Meir et al., "Coenzyme Q10 restores oocyte mitochondrial function and fertility during reproductive aging," Aging Cell, 14(5), 2015.
  • Lin et al., "Clinical evidence of coenzyme Q10 pretreatment for women with diminished ovarian reserve undergoing IVF/ICSI: a systematic review and meta-analysis," Annals of Medicine, 56(1), 2024.
nLIV / D3K2‑03

D3 + K2

Vitamin D receptors are present in both testes and ovarian tissue, and population studies consistently find lower vitamin D status in infertile men and women compared with fertile controls, alongside associations with sperm motility and morphology. Vitamin K2 is included because it governs how the body uses the calcium that vitamin D helps absorb, and animal work links K2 deficiency to reduced sperm count and motility. Trial results for supplementation are more mixed than the observational data, which is typical for a nutrient this broadly involved in physiology.

Further reading
  • "The association between serum vitamin D, fertility and semen quality: a systematic review and meta-analysis," PubMed, 2019.
  • Cito et al., "Vitamin D and male fertility: an updated review," World Journal of Men's Health, 38(2), 2020.
nLIV / MULTI‑04

Multivitamin

Folate is the best-established nutrient in reproductive health: umbrella reviews of decades of trial and cohort data show that periconceptional folic acid and multivitamin use meaningfully lowers the risk of neural tube defects, which is why clinical guidelines recommend it before conception rather than after a positive test. We built the multivitamin around that same preconception window, so the foundational nutrients are on board before they're needed rather than after.

Further reading
  • "Preconception folic acid and multivitamin supplementation for the prevention of neural tube defect: an umbrella review of systematic reviews and meta-analyses," Neuroepidemiology, Karger.
  • "Guideline No. 427: Folic acid and multivitamin supplementation for prevention of folic acid-sensitive congenital anomalies," Journal of Obstetrics and Gynaecology Canada, 2022.
nLIV / RESV‑05

Resveratrol

Resveratrol is an antioxidant studied for its ability to reduce oxidative stress in the granulosa cells that support a developing egg, with animal work linking it to better oocyte quality and a longer ovarian lifespan. Human evidence is genuinely split: some trials report better oocyte maturation, while one large retrospective study of IVF cycles found lower pregnancy rates at higher intake, likely tied to effects on the uterine lining rather than the egg itself. We formulate at the lower end of studied doses for that reason, and see this as the product to discuss with a doctor if pregnancy is imminent.

Further reading
  • "Resveratrol supplementation and reproductive health: a systematic review," International Journal of Molecular Sciences, 2025.
  • Ochiai et al., "Influence of resveratrol supplementation on IVF-embryo transfer cycle outcomes," Reproductive BioMedicine Online, 2019.
nLIV / FOLIC‑06

Folic acid

Folic acid's role in preventing neural tube defects is one of the most replicated findings in reproductive medicine, dating back to the landmark Medical Research Council trial that halved recurrence risk in high-risk pregnancies. Because the neural tube closes before most people know they're pregnant, the protective window falls before conception — which is why we offer folic acid as its own product for anyone building a stack around it rather than a bundled multivitamin.

Further reading
  • MRC Vitamin Study Research Group, "Prevention of neural tube defects: results of the Medical Research Council Vitamin Study," The Lancet, 1991.
  • "Folate deficiency and folic acid supplementation: the prevention of neural-tube defects and congenital heart defects," reproductive health review.

Why nLIV

A narrow line, chosen on purpose.

We would rather ship four formulations we can stand behind than forty that compete with each other on the shelf. Every product in the line earns its place by supporting a distinct, well-understood mechanism in the fertility pathway.

01

Single-mechanism design

Each product is built around one active role, not a blend of everything at once.

02

Considered dosing

Doses are set against the research on each ingredient, not rounded to a marketing number.

03

Both partners in view

Fertility is treated as a shared process, with formulations for women, men and both.

04

Built in Switzerland

Formulated and quality-controlled to Swiss manufacturing standards from the outset.

nLIV formulations are developed in ongoing collaboration with university hospital research groups. We're not naming institutions or sharing details yet — that information will follow as those partnerships are formalized.

Beyond the supplement line

Soon to come.

The nLIV supplement line is the first branch of a broader reproductive health effort. Additional branches are in development and will be introduced here as they're ready.